One of the core values of Open Medicine is that we do not take money from pharmaceutical companies (”Big Pharma”) or medical device companies. Many physicians and scientists agree that taking money from drug companies can create the appearance of a conflict of interest, if not an actual CoI.
National Public Radio has a program posted today entitled ‘Doctors Reject Drug Company Cash’ about a number of doctors who formerly would get paid for making speeches. Now they say they are reclaiming their tarnished credibility.
Madeleine Brand talks to Dr. Peter Libby, chief of cardiovascular medicine at Brigham and Women’s Hospital in Boston, about his decision to move away from the practice of taking money from drug companies.
Tags: 'Doctors Reject Drug Company Cash' - Clarifying the Purpose of Medical Science
